Cargando…
Changes in Invasive Pneumococcal Disease in the Paediatric Population in the Second COVID-19 Pandemic Year
Incidence of invasive pneumococcal disease (IPD) decreased worldwide in 2020, coinciding with the implementation of measures to reduce COVID-19 transmission. We evaluated the impact of the COVID-19 pandemic on healthcare demand and IPD in children in 2021 compared to the pre-pandemic period (2018–20...
Autores principales: | Izquierdo, Conchita, Ciruela, Pilar, Soldevila, Núria, Garcia-Garcia, Juan-Jose, Gonzalez-Peris, Sebastia, Díaz-Conradi, Alvaro, Viñado, Belen, F de Sevilla, Mariona, Moraga-Llop, Fernando, Muñoz-Almagro, Carmen, Domínguez, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611414/ https://www.ncbi.nlm.nih.gov/pubmed/37896951 http://dx.doi.org/10.3390/vaccines11101548 |
Ejemplares similares
-
Effect of COVID-19 Pandemic on Invasive Pneumococcal Disease in Children, Catalonia, Spain
por: Ciruela, Pilar, et al.
Publicado: (2022) -
Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control study
por: Domínguez, Ángela, et al.
Publicado: (2017) -
Failures of 13-Valent Conjugated Pneumococcal Vaccine in Age-Appropriately Vaccinated Children 2–59 Months of Age, Spain
por: Hernández, Sergi, et al.
Publicado: (2020) -
Impact of the 13-Valent Conjugated Pneumococcal Vaccine on the Direct Costs of Invasive Pneumococcal Disease Requiring Hospital Admission in Children Aged < 5 Years: A Prospective Study
por: Hernández, Sergi, et al.
Publicado: (2020) -
Serotype and clonal distribution dynamics of invasive pneumococcal strains after PCV13 introduction (2011-2016): Surveillance data from 23 sites in Catalonia, Spain
por: Ludwig, Guillermo, et al.
Publicado: (2020)